Literature DB >> 18627247

An internal polyadenylation signal substantially increases expression levels of lentivirus-delivered transgenes but has the potential to reduce viral titer in a promoter-dependent manner.

Stefanie Hager1, Fiona M Frame, Anne T Collins, Julie E Burns, Norman J Maitland.   

Abstract

In lentiviral gene delivery systems, transgene expression cassettes are commonly cloned without a polyadenylation signal to prevent disruption of full-length lentiviral genomes on mRNA maturation in producer cells. The lack of the polyadenylation signal, however, has the potential to reduce stability and translation efficiency of transgene mRNA. Therefore, we have assessed the effect of a strong internal polyadenylation [poly(A)] signal on both transgene expression levels in virus-infected cells and functional viral titer, in a series of eight self-inactivating lentiviruses expressing the mOrange transgene under the control of the constitutive cytomegalovirus (CMV), elongation factor 1alpha (EF1alpha), and beta-actin promoters or the highly tissue-specific prostate-specific antigen/probasin hybrid (PSA/Pb) promoter with or without a simian virus 40 (SV40) early polyadenylation signal downstream of the mOrange-coding sequence. We show that mOrange expression levels in virus-infected HEK-293, LNCaP, and primary prostate epithelial cells were increased 3- to 6.5-fold when an internal polyadenylation signal was present. When the CMV and EF1alpha promoters were used, functional viral titer decreased 8- to 9-fold in the presence of the polyadenylation signal, but titer was not affected when transgene expression was driven by the beta-actin promoter or tissue-specific PSA/Pb promoter. We therefore conclude that an internal polyadenylation signal in lentiviral vectors has a highly beneficial effect on transgene expression, but reduces viral titer in a promoter-dependent manner.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18627247     DOI: 10.1089/hum.2007.165

Source DB:  PubMed          Journal:  Hum Gene Ther        ISSN: 1043-0342            Impact factor:   5.695


  14 in total

1.  Titers of lentiviral vectors encoding shRNAs and miRNAs are reduced by different mechanisms that require distinct repair strategies.

Authors:  Ying Poi Liu; Monique A Vink; Jan-Tinus Westerink; Eva Ramirez de Arellano; Pavlina Konstantinova; Olivier Ter Brake; Ben Berkhout
Journal:  RNA       Date:  2010-05-24       Impact factor: 4.942

Review 2.  Methods for gene transfer to the central nervous system.

Authors:  Boris Kantor; Rachel M Bailey; Keon Wimberly; Sahana N Kalburgi; Steven J Gray
Journal:  Adv Genet       Date:  2014       Impact factor: 1.944

3.  Genome-wide CRISPR Analysis Identifies Substrate-Specific Conjugation Modules in ER-Associated Degradation.

Authors:  Dara E Leto; David W Morgens; Lichao Zhang; Christopher P Walczak; Joshua E Elias; Michael C Bassik; Ron R Kopito
Journal:  Mol Cell       Date:  2018-12-20       Impact factor: 17.970

4.  High level of fetal-globin reactivation by designed transcriptional activator-like effector.

Authors:  Jun Zhan; Maria Johnson Irudayam; Yukio Nakamura; Ryo Kurita; Arthur W Nienhuis
Journal:  Blood Adv       Date:  2020-02-25

5.  DNA hypermethylation in prostate cancer is a consequence of aberrant epithelial differentiation and hyperproliferation.

Authors:  D Pellacani; D Kestoras; A P Droop; F M Frame; P A Berry; M G Lawrence; M J Stower; M S Simms; V M Mann; A T Collins; G P Risbridger; N J Maitland
Journal:  Cell Death Differ       Date:  2014-01-24       Impact factor: 15.828

Review 6.  Evading the immune response upon in vivo gene therapy with viral vectors.

Authors:  Brandon K Sack; Roland W Herzog
Journal:  Curr Opin Mol Ther       Date:  2009-10

7.  Prostate cancer stem cells: do they have a basal or luminal phenotype?

Authors:  Norman J Maitland; Fiona M Frame; Euan S Polson; John L Lewis; Anne T Collins
Journal:  Horm Cancer       Date:  2011-02       Impact factor: 3.869

8.  Novel lentiviral vectors with mutated reverse transcriptase for mRNA delivery of TALE nucleases.

Authors:  Ulrike Mock; Kristoffer Riecken; Belinda Berdien; Waseem Qasim; Emma Chan; Toni Cathomen; Boris Fehse
Journal:  Sci Rep       Date:  2014-09-18       Impact factor: 4.379

9.  A MultiSite Gateway Toolkit for Rapid Cloning of Vertebrate Expression Constructs with Diverse Research Applications.

Authors:  Daniel K Fowler; Scott Stewart; Steve Seredick; Judith S Eisen; Kryn Stankunas; Philip Washbourne
Journal:  PLoS One       Date:  2016-08-08       Impact factor: 3.240

Review 10.  Recombinant Adeno-Associated Viral Vectors (rAAV)-Vector Elements in Ocular Gene Therapy Clinical Trials and Transgene Expression and Bioactivity Assays.

Authors:  Thilo M Buck; Jan Wijnholds
Journal:  Int J Mol Sci       Date:  2020-06-12       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.